Forte Biosciences, Inc.

NasdaqCM:FBRX Lagerbericht

Marktkapitalisierung: US$6.1m

Forte Biosciences Dividende

Zukünftiges Wachstum Kriterienprüfungen 0/6

Forte Biosciences does not have a record of paying a dividend.

Wichtige Informationen

n/a

Dividendenausschüttung

-404.4%

Rückkaufsrendite

Gesamte Aktionärsrendite-404.4%
Zukünftige Dividendenrenditen/a
Wachstum der Dividenden/a
Nächster Dividendenzahlungsterminn/a
Ex-Dividendendatumn/a
Dividende pro Aktien/a
Ausschüttungsquoten/a

Aktuelle Dividendenentwicklung

Keine Aktualisierungen

Recent updates

We're A Little Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Jul 17
We're A Little Worried About Forte Biosciences' (NASDAQ:FBRX) Cash Burn Rate

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?

Mar 14
Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans?

Large Forte Biosciences shareholder scolds company board of directors

Aug 24

We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Aug 17
We're Hopeful That Forte Biosciences (NASDAQ:FBRX) Will Use Its Cash Wisely

Forte Biosciences: Lots Of Clinical Risk Ahead And A Questionable Business Plan

Aug 16

Forte Biosciences large shareholders make demands for company's future

Jul 07

We Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth Carefully

Dec 23
We Think Forte Biosciences (NASDAQ:FBRX) Needs To Drive Business Growth Carefully

Forte Biosciences files for $300M mixed shelf offering

May 28

Are Insiders Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Stock?

Mar 13
Are Insiders Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Stock?

Do Institutions Own Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Jan 19
Do Institutions Own Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Forte Biosciences: FB-401 Potentially Best-In-Class In Atopic Dermatitis

Dec 18

Who Has Been Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Nov 25
Who Has Been Buying Forte Biosciences, Inc. (NASDAQ:FBRX) Shares?

Forte Biosciences readies equity offering

Oct 28

Stabilität und Wachstum des Zahlungsverkehrs

Rufe Dividendendaten ab

Stabile Dividende: Insufficient data to determine if FBRX's dividends per share have been stable in the past.

Wachsende Dividende: Insufficient data to determine if FBRX's dividend payments have been increasing.

Dividendenrendite im Vergleich zum Markt

Forte Biosciences Dividendenrendite im Vergleich zum Markt
Wie sieht die Dividendenrendite von FBRX im Vergleich zum Markt aus?
SegmentDividendenrendite
Unternehmen (FBRX)n/a
Untere 25 % des Marktes (US)1.5%
Markt Top 25 % (US)4.5%
Branchendurchschnitt (Biotechs)2.2%
Analystenprognose (FBRX) (bis zu 3 Jahre)n/a

Bemerkenswerte Dividende: Unable to evaluate FBRX's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Hohe Dividende: Unable to evaluate FBRX's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Gewinnausschüttung an die Aktionäre

Abdeckung der Erträge: Insufficient data to calculate FBRX's payout ratio to determine if its dividend payments are covered by earnings.

Barausschüttung an die Aktionäre

Cashflow-Deckung: Unable to calculate sustainability of dividends as FBRX has not reported any payouts.

Entdecken Sie dividendenstarke Unternehmen

7D

1Y

7D

1Y

7D

1Y